Pure Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Pure Financial Advisors's VRTX Position: Q2 2026 in Review
Pure Financial Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 14% in Q2 2026, buying an estimated $179K and bringing the position to 3,310 shares worth $1.64M. The position accounts for 0.02% of the portfolio, ranked #198.
Pure Financial Advisors first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Pure Financial Advisors held 3,310 shares of Vertex Pharmaceuticals worth $1.64M as of Q2 2026.
- Pure Financial Advisors bought 404 Vertex Pharmaceuticals shares in Q2 2026, an estimated $179K.
- Vertex Pharmaceuticals made up 0.02% of Pure Financial Advisors's portfolio in Q2 2026, its #198 holding.
- Pure Financial Advisors first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Pure Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.